Olmesartan endothelial function in patients with essential hypertension and renal function in.docVIP

Olmesartan endothelial function in patients with essential hypertension and renal function in.doc

  1. 1、本文档共4页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Olmesartan endothelial function in patients with essential hypertension and renal function in

 PAGE \* MERGEFORMAT 4 Olmesartan endothelial function in patients with essential hypertension and renal function in [Keywords:] vascular endothelial Can secrete a variety of vascular endothelial vasoactive substances to regulate vascular tone and structure to maintain the balance between coagulation and fibrinolysis, and hypertension, atherosclerosis and other diseases is closely related to the occurrence and development [1]. This study by measuring plasma endothelin -1 (ET-1), a nitric oxide (NO) and urinary microalbumin (U-MALB), urinary β 2-microglobulin (β 2-MG), of essential hypertension Patients with vascular endothelial function and renal function changes and the intervention of the role of olmesartan are reported below. 1 Data and methods 1.1 General Information May-August 2007 Cardiology in our hospital out-patient and hospitalization with mild to moderate essential hypertension 40 patients (treatment group), male 22 cases, female 18 cases; average age (63.2 ± 15.2) years of age. Are ruled out chronic congestive heart failure and chronic kidney insufficiency. 40 cases of healthy adults as a control group, male 22 cases, female 18 cases; average age (62.9 ± 16.1) years of age. 1.2 Methods (1) Delivery Methods: Hypertensive patients to stop taking the original half-life of five antihypertensive drugs and then entered clinical trials. Give Olmesartan (made in Shanghai) 20 mg oral, 1 time / d, were treated for 4 weeks. (2) determination of indicators: the treatment group in clinical trials, medication 4 weeks before and after the mining and venous blood and urine using radioimmunoassay ET-1 levels, nitrate reductase Determination of NO level, adsorption measured U-MALB and radioimmunoassay determination of urinary β 2-MG. Detection kit according to the instructions requested. Determination of the control group, only one time. 1.3 Statistical analysis All data are mean ± standard deviation (x ± s) indicated. Using t test. 2 Results Olmesarta

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档